Life Technologies Acquires BAC | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies today announced that it has acquired Dutch firm BAC BV for an undisclosed sum.

BAC makes protein purification products and will expand Life Tech's portfolio in bioprocessing by adding the firm's affinity ligands to Life Tech's Poros brand of chromatography resins for purification of therapeutic products. The new technologies also complement Life Tech's Gibco brand of cell culture media products and the Applied Biosystems SEQ rapid molecular kits for containment and impurity testing of biotherapeutic products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.